BCL2 and breast cancer: It has been reported that 17β-estradiol inhibits MDA-MB-231 breast cancer cell growth by increasing BAX/BCL-2 and reducing pERK1/2[33], while it is mostly agreed that it promotes proliferation and cell-cycle progression of MCF-7 cells.